CSCIF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - COSCIENS Biopharma Inc

Watchlist Manager

Watchlist

Price: 1.93 USD 2.66% Market Closed

Market Cap: $6.1m

	COSCIENS Biopharma Inc OTC:CSCIF	CA
B	BRP Inc F:B15A	CA
B	Banco Santander SA XBER:BSD2	ES
	Magmatic Resources Ltd ASX:MAG	AU
	Archos SA F:AYH0	FR
	Perusahaan Gas Negara Tbk PT OTC:PPAAF	ID
M	Motorola Solutions Inc XBER:MTLA	US
T	Telefonaktiebolaget LM Ericsson XBER:ERCB	SE

Profitability Summary

COSCIENS Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

35%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

98% > 35%

Negative Operating Margin

-138%

Negative 3Y Average Operating Margin

-227%

Operating Margin is Increasing

-399% > -138%

Negative Net Margin

-138%

Negative 3Y Average Net Margin

-211%

Net Margin is Increasing

-389% > -138%

Negative Free Cash Flow Margin

-122%

Negative 3Y Average Free Cash Flow Margin

-197%

Free Cash Flow Margin is Increasing

-260% > -122%

Negative ROE

-122%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-792%

ROIC is Increasing

-407% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

35%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

98% > 35%

Negative Operating Margin

-138%

Negative 3Y Average Operating Margin

-227%

Operating Margin is Increasing

-399% > -138%